MedTrace Logo

Scapular PNF Versus Shoulder Strengthening Exercises in Patients With Lateral Epicondylitis.

NCT05947968 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2023-07-17

No results posted yet for this study

Summary

The purpose of this study is to compare between the effect of scapular proprioceptive neuromuscular facilitation versus shoulder and scapular strengthening exercise on pain, functional outcome and grip strength in patients with lateral epicondylitis.

Conditions

  • Lateral Epicondylitis

Interventions

OTHER

Scapular PNF

Scapular proprioceptive neuromuscular facilitation exercise: will be applied in two diagonals: 1. anterior elevation and posterior depression 2. posterior elevation and anterior depression for 3 sets of 10 repetitions, The rest interval between sets will be 20 seconds. Patients will lay on the unaffected side while the therapist stands in the line of desired motion. Firstly, the therapist will give preparatory instructions. In the beginning of the pattern, the therapist pulls the scapula to the elongated position and then gives instructions for the desired movement.

OTHER

Shoulder strengthening exercises

Shoulder strengthening exercises: The following four exercises will focus on shoulder and scapular strengthening. Before starting the program, the patients will be thoroughly instructed in the four exercises, and illustrations with specific exercise instructions will be provided. All subjects will perform the exercises with the affected side for three sets of 10 repetitions for each exercise, with a 1-minute rest between sets. 1. Standing shoulder external rotation with elastic resistance. 2. Bilateral external rotation with scapular retraction exercise. 3. Resisted scapular retraction with shoulder external rotation (Middle trapezius muscle). 4. Weighted scapular retraction and downward rotation Y-shape (lower trapezius muscle).

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Mahmoud Essam Abu Elfetouh Ghallab

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-15
Primary Completion
2023-09-30
Completion
2023-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05947968 on ClinicalTrials.gov